chr4-76180995-G-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBS1_SupportingBS2

The NM_005506.4(SCARB2):​c.382C>T​(p.Pro128Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,461,098 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P128A) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000023 ( 2 hom. )

Consequence

SCARB2
NM_005506.4 missense

Scores

1
7
10

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:6

Conservation

PhyloP100: 3.00

Publications

3 publications found
Variant links:
Genes affected
SCARB2 (HGNC:1665): (scavenger receptor class B member 2) The protein encoded by this gene is a type III glycoprotein that is located primarily in limiting membranes of lysosomes and endosomes. Earlier studies in mice and rat suggested that this protein may participate in membrane transportation and the reorganization of endosomal/lysosomal compartment. The protein deficiency in mice was reported to impair cell membrane transport processes and cause pelvic junction obstruction, deafness, and peripheral neuropathy. Further studies in human showed that this protein is a ubiquitously expressed protein and that it is involved in the pathogenesis of HFMD (hand, foot, and mouth disease) caused by enterovirus-71 and possibly by coxsackievirus A16. Mutations in this gene caused an autosomal recessive progressive myoclonic epilepsy-4 (EPM4), also known as action myoclonus-renal failure syndrome (AMRF). Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
SCARB2 Gene-Disease associations (from GenCC):
  • action myoclonus-renal failure syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • progressive myoclonus epilepsy
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia
  • Unverricht-Lundborg syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24713436).
BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.0000226 (33/1461098) while in subpopulation MID AF = 0.00313 (18/5760). AF 95% confidence interval is 0.00202. There are 2 homozygotes in GnomAdExome4. There are 24 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005506.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
NM_005506.4
MANE Select
c.382C>Tp.Pro128Ser
missense
Exon 3 of 12NP_005497.1Q14108-1
SCARB2
NM_001204255.2
c.276-5085C>T
intron
N/ANP_001191184.1Q14108-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SCARB2
ENST00000264896.8
TSL:1 MANE Select
c.382C>Tp.Pro128Ser
missense
Exon 3 of 12ENSP00000264896.2Q14108-1
SCARB2
ENST00000640634.1
TSL:5
c.358C>Tp.Pro120Ser
missense
Exon 3 of 13ENSP00000492737.1A0A1W2PRS1
SCARB2
ENST00000862445.1
c.382C>Tp.Pro128Ser
missense
Exon 3 of 12ENSP00000532504.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.0000678
AC:
17
AN:
250876
AF XY:
0.0000959
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000529
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.0000226
AC:
33
AN:
1461098
Hom.:
2
Cov.:
30
AF XY:
0.0000330
AC XY:
24
AN XY:
726816
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33462
American (AMR)
AF:
0.0000224
AC:
1
AN:
44668
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39612
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86116
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53322
Middle Eastern (MID)
AF:
0.00313
AC:
18
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000900
AC:
10
AN:
1111698
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60350
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000109
Hom.:
1
Bravo
AF:
0.0000151
ExAC
AF:
0.0000906
AC:
11
EpiCase
AF:
0.0000546
EpiControl
AF:
0.0000593

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Action myoclonus-renal failure syndrome (2)
-
2
-
not provided (2)
-
1
-
Inborn genetic diseases (1)
-
1
-
Progressive myoclonic epilepsy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.42
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.30
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.48
T
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.25
T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.2
L
PhyloP100
3.0
PrimateAI
Benign
0.35
T
PROVEAN
Pathogenic
-4.4
D
REVEL
Uncertain
0.34
Sift
Uncertain
0.016
D
Sift4G
Uncertain
0.011
D
Polyphen
0.80
P
Vest4
0.21
MutPred
0.48
Gain of relative solvent accessibility (P = 0.0479)
MVP
0.78
MPC
0.33
ClinPred
0.23
T
GERP RS
3.2
Varity_R
0.79
gMVP
0.49
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143558324; hg19: chr4-77102148; API